Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis
Atherosclerosis (AS) is a disorder of large and medium-sized arteries; it consists in the formation of lipid-rich plaques in the intima and inner media, whose pathophysiology is mostly driven by inflammation. Currently available interventions and therapies for treating atherosclerosis are not always...
Main Authors: | Antonio Cervadoro, Roberto Palomba, Giuseppe Vergaro, Roberta Cecchi, Luca Menichetti, Paolo Decuzzi, Michele Emdin, Stefano Luin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2018.00177/full |
Similar Items
-
Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice
by: Qi Wang, et al.
Published: (2021-07-01) -
Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics
by: Amreen Khan, et al.
Published: (2021-01-01) -
Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy
by: Valeria Verde, et al.
Published: (2020-08-01) -
Nanomaterials incorporated ultrasound contrast agents for cancer theranostics
by: Lei Fu, et al.
Published: (2016-09-01) -
Treatment of Biofilm Communities: An Update on New Tools from the Nanosized World
by: Federico Bertoglio, et al.
Published: (2018-05-01)